elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68
Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68
Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?
P2860
Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d583df564842208d3844fa98a215b45d752ae03
P2860
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.